Last update Dec. 20, 2022
Very Low Risk
We do not have alternatives for J05AB01 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
J05AB01 is Acyclovir; Aciclovir in ATC Code/s.Is written in other languages:
J05AB01 belongs to these groups or families:
Main tradenames from several countries containing J05AB01 in its composition:
|Oral Bioavail.||15 - 30||%|
|Protein Binding||10 - 30||%|
|Tmax||1.5 - 2||hours|
|T½||2 - 3||hours|
|M/P ratio||1 - 3||-|
|Theoretical Dose||0.9 - 1.5||mg/Kg/d|
|Relative Dose||1 - 2.5||%|
|Ped.Relat.Dose||1.8 - 3.6||%|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Antiviral very active against Herpes simplex and Herpes zoster-varicella. Intravenous, oral and topical (dermatological and ophthalmological) administration. Its use is authorized in newborns and infants.
Despite its higher concentration in breast milk than in plasma (Mactal 2001,Bork 2000, Lau 1987), it is excreted in breast milk in a clinically insignificant amount (Drake 2012, Bork 1995, Taddio 1994, Don 1991, Meyer 1988, Lau 1987), much lower than the dose used in newborns and infants (Sheffield 2002), and no problems have been observed in infants whose mothers took it. (Agarwal 2019, Taddio 1994)
Systemic absorption of topical cutaneous acyclovir is negligible. (Mactal 2001)
List of WHO essential medicines: compatible with breastfeeding (WHO / UNICEF 2002). American Academy of Pediatrics: medication usually compatible with breastfeeding. (AAP 2001)
See below the information of these related products: